EDGAR Filing Documents for 0001144204-19-033595

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001144204-19-033595

Filing Date

2019-07-02

Accepted

2019-07-02 16:20:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	tv524703_424b5.htm	424B5	869088
2	GRAPHIC	tv524703_img1.jpg	GRAPHIC	8705
3	GRAPHIC	tv524703_img2.jpg	GRAPHIC	67057
	Complete submission text file	0001144204-19-033595.txt		974901

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B5 | Act: 33 | File No.: 333-220052 | Film No.: 19937668
SIC: 2834 Pharmaceutical Preparations